https://www.fiercepharma.com/pharma/sanofi-regenerons-dupixent-destined-20b-peak-sales-potential-copd-expansion-analyst
0
0
COPD nod could be worth $3.5B for Sanofi, Regeneron's Dupixent - FiercePharma
3/24/23 at 5:25pm
Organization
FiercePharma
Author
FiercePharma
Details
13 words
Summarize
Create an account or login to join the discussion